☆ 4.5 Article

Evaluation of the In-Use Stability of Monoclonal Antibody IV Admixtures Prepared from Drug Products Containing Polysorbate 20 Degraded by Host-Cell Lipases

JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Article Biochemical Research Methods

Monitoring polysorbate hydrolysis in therapeutic proteins using an ultrasensitive extraction-free fatty acid quantitation method

Sisi Zhang et al.

Summary: A rapid lipase activity assay was introduced for accurate quantitation of free fatty acids without the need for a fatty acid extraction step. This assay can detect low levels of PS degradation within 1 day and the released free fatty acids correlate strongly with the degree of PS20 degradation.

ANALYTICAL BIOCHEMISTRY (2022)

Add to Collection

Article Chemistry, Medicinal

Quantitative Evaluation of Insoluble Particulate Matters in Therapeutic Protein Injections Using Light Obscuration and Flow Imaging Methods

Hiroko Shibata et al.

Summary: This study compared the effectiveness of flow imaging (FI) and light obscuration (LO) methods in evaluating insoluble particles in therapeutic protein injections. The results showed that FI method yielded higher particle counts compared to LO method, and the difference varied depending on the products or features of particles.

JOURNAL OF PHARMACEUTICAL SCIENCES (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Identification of the specific causes of polysorbate 20 degradation in monoclonal antibody formulations containing multiple lipases

Sisi Zhang et al.

Summary: This study determines that lysosomal acid lipase (LAL) is the cause of PS degradation and provides a practical strategy to determine the root cause of PS degradation.

PHARMACEUTICAL RESEARCH (2022)

Add to Collection

Article Chemistry, Medicinal

An Intercompany Perspective on Compatibility and In-use Stability Studies to Enable Administration Of Biopharmaceutical Drug Products

Douglas E. Kamen et al.

Summary: This article discusses an inter-company collaboration exercise conducted by the Formulation Workstream of the BioPhorum Development Group (BPDG) to understand current industry approaches for in-use stability and compatibility studies of biologic drugs. The survey results provide insights into common industry practices and offer various approaches to guide the design of an in-use stability and compatibility program based on clinical and biomolecule needs.

JOURNAL OF PHARMACEUTICAL SCIENCES (2022)

Add to Collection

Article Chemistry, Medicinal

Human Serum Albumin Mitigates Formation of Fatty Acid Particles in Polysorbate-Containing Solutions

Dorothy M. Kim et al.

Summary: Monoclonal antibody therapeutics often contain polysorbate for stabilizing effects, but this may lead to particle formation. The presence of human serum albumin can prevent and dissolve fatty acid particles, providing a plausible explanation for previous observations and reducing concerns about particle levels in the final drug product.

JOURNAL OF PHARMACEUTICAL SCIENCES (2022)

Add to Collection

Article Chemistry, Medicinal

Dissolution of Polysorbate 20 Degradation Related Free Fatty Acid Particles in Intravenous Bag Solutions

Nidhi Doshi et al.

Summary: The degradation of Polysorbate 20 (PS20) in drug product formulations can lead to the generation of free fatty acids (FFAs) which can form visible and/or sub-visible particles. However, the FFAs particles dissolve immediately upon dilution in intravenous solutions, reducing the risk of these particles being administered to a patient intravenously.

JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Add to Collection

Article Chemistry, Medicinal

In-Use Interfacial Stability of Monoclonal Antibody Formulations Diluted in Saline i.v. Bags

Aadithya Kannan et al.

Summary: The use of monoclonal antibodies (mAbs) for disease treatment is increasing rapidly, with a higher aggregation propensity observed in saline compared to low ionic strength formulation buffer. The presence of salt in buffer with surfactants leads to greater mAb adsorption at the interface and the formation of more particulate aggregates. Stress studies for mAb formulations intended for intravenous administration should be performed in conditions representative of their intended route of administration.

JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Add to Collection

Article Chemistry, Medicinal

Extended Characterization and Impact of Visible Fatty Acid Particles - A Case Study With a mAb Product

Miguel Saggu et al.

Summary: This study presents a case analysis of visible particles in biopharmaceutical formulations, specifically focusing on particles resulting from the degradation of the surfactant polysorbate 20. Through techniques such as mass spectrometry, Raman spectroscopy, and flow imaging microscopy, the identity and composition of the particles were determined to support risk assessments. The impact of saline and human plasma exposure on the fate of these particles upon dilution and/or administration was also evaluated to better understand their behavior in clinical settings.

JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Add to Collection

Review Chemistry, Medicinal

A review of formulations of commercially available antibodies

Robert G. Strickley et al.

Summary: This review examines 126 commercially available antibodies approved globally between 1986 and February 2021, including various formulations, routes of administration, and formulation components. The number of approved antibodies per year has increased significantly after 2014. Most antibody products are packaged in single-dose units, with different routes of administration and formulation components.

JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Add to Collection

Article Chemistry, Medicinal

Polysorbate Degradation and Particle Formation in a High Concentration mAb: Formulation Strategies to Minimize Effect of Enzymatic Polysorbate Degradation

Ian Roy et al.

Summary: This manuscript summarizes the investigation of a batch of high concentration (>100 mg/mL) mAb DP where subvisible particles formed abruptly after prolonged storage at 5°C degrees. The concentration and fatty acid composition of polysorbates were found to be significant factors in particle development. Solubilizers and alternative surfactants were all shown to be effective means of preventing particle formation.

JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Add to Collection

Editorial Material Biotechnology & Applied Microbiology

Stability of Biologics and the Quest for Polysorbate Alternatives

Sachin Dubey et al.

Summary: Most biopharmaceutical formulations currently rely on polysorbates, which are highly efficient but challenging to control in terms of quality and stability. However, alternatives such as poloxamers, albumin, and cyclodextrin are gaining popularity for their potential to protect biopharmaceuticals against physical and mechanical stresses.

TRENDS IN BIOTECHNOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Defining the right diluent for intravenous infusion of therapeutic antibodies

Shen Luo et al.

MABS (2020)

Add to Collection

Article Pharmacology & Pharmacy

Acidic and alkaline hydrolysis of polysorbates under aqueous conditions: Towards understanding polysorbate degradation in biopharmaceutical formulations

Mridula Dwivedi et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Add to Collection

Review Pharmacology & Pharmacy

Rational design to biologics development: The polysorbates point of view

Ema Valentina Brovc et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)

Add to Collection

Article Chemistry, Medicinal

Evaluation of Super Refined™ Polysorbate 20 With Respect to Polysorbate Degradation, Particle Formation and Protein Stability

Nidhi Doshi et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Considerations for the Use of Polysorbates in Biopharmaceuticals

Michael T. Jones et al.

PHARMACEUTICAL RESEARCH (2018)

Add to Collection

Review Pharmacology & Pharmacy

Polysorbate degradation in biotherapeutic formulations: Identification and discussion of current root causes

Mridula Dwivedi et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)

Add to Collection

Review Pharmacology & Pharmacy

Effect of Surfactants on Mechanical, Thermal, and Photostability of a Monoclonal Antibody

Meera Agarkhed et al.

AAPS PHARMSCITECH (2018)

Add to Collection

Editorial Material Chemistry, Medicinal

An Approach to Mitigate Particle Formation on the Dilution of a Monoclonal Antibody Drug Product in an IV Administration Fluid

Songyan Zheng et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2016)

Add to Collection

Article Chemistry, Medicinal

Polysorbates 20 and 80 Degradation by Group XV Lysosomal Phospholipase A2 Isomer X1 in Monoclonal Antibody Formulations

Troii Hall et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2016)

Add to Collection

Article Medicine, Research & Experimental

Understanding Particle Formation: Solubility of Free Fatty Acids as Polysorbate 20 Degradation Byproducts in Therapeutic Monoclonal Antibody Formulations

Nidhi Doshi et al.

MOLECULAR PHARMACEUTICS (2015)

Add to Collection

Article Chemistry, Multidisciplinary

Small Amounts of Sub-Visible Aggregates Enhance the Immunogenic Potential of Monoclonal Antibody Therapeutics

Maryam Ahmadi et al.

PHARMACEUTICAL RESEARCH (2015)

Add to Collection

Article Pharmacology & Pharmacy

Effect of solution properties on the counting and sizing of subvisible particle standards as measured by light obscuration and digital imaging methods

Tobias Werk et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)

Add to Collection

Review Toxicology

Immunogenicity of therapeutic proteins: Influence of aggregation

Kirsty D. Ratanji et al.

JOURNAL OF IMMUNOTOXICOLOGY (2014)

Add to Collection

Article Chemistry, Medicinal

Stability of IgG1 monoclonal antibodies in intravenous infusion bags under clinical in-use conditions

Alavattam Sreedhara et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2012)

Add to Collection

Article Chemistry, Medicinal

Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags

Ozan S. Kumru et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2012)

Add to Collection

Article Chemistry, Multidisciplinary

The Degradation of Polysorbates 20 and 80 and its Potential Impact on the Stability of Biotherapeutics

Ravuri S. K. Kishore et al.

PHARMACEUTICAL RESEARCH (2011)

Add to Collection

Review Biochemistry & Molecular Biology

A Critical Review of Analytical Methods for Subvisible and Visible Particles

Linda O. Narhi et al.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2009)

Add to Collection

Article Chemistry, Medicinal

Quantitation of Protein Particles in Parenteral Solutions Using Micro-Flow Imaging

Chi-Ting Huang et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.